Lucid Diagnostics Incis A Commercial Stage Medical Diagnostics Company Based In New York Cityfounded In 2018 And A Subsidiary Of Pavmed Inc The Company Is Dedicated To Early Cancer Detectionspecifically Targeting Esophageal Adenocarcinomaeac Its Mission Is To Prevent Esophageal Cancer Deaths Through The Early Detection Of Precancerous Conditions Using Non Invasive Technologies The Company Offers Two Main Productsesochecka A Minimally Invasive Device For Collecting Esophageal Cellsand Esoguarda A Dna Test That Analyzes Biomarkers Linked To Esophageal Precancerthese Products Primarily Serve Patients With Chronic Gastroesophageal Reflux Diseasegerdwho Are At Risk For Eaclucid Diagnostics Generates Revenue Through Test Salespartnerships With Gastroenterology Clinicsand Insurance Reimbursementspositioning Itself As The First Commercial Solution For Widespread Eac Precancer Detection
No conferences found for this company.
| Company Name | Lucid Diagnostics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
